BLANENT Trademark

Trademark Overview

On Friday, November 9, 2012, a trademark application was filed for BLANENT with the United States Patent and Trademark Office. The USPTO has given the BLANENT trademark a serial number of 85775765. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 21, 2023. This trademark is owned by Glaxo Group Limited. The BLANENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal and substances: vaccines; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
blanent

General Information

Serial Number85775765
Word MarkBLANENT
Filing DateFriday, November 9, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 21, 2023
Registration Number5056991
Registration DateTuesday, October 11, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2013

Trademark Statements

Goods and ServicesPharmaceutical and medicinal and substances: vaccines; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, April 21, 2023CANCELLED SEC. 8 (6-YR)
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 11, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 8, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 31, 2016NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 31, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2015SOU EXTENSION 5 GRANTED
Wednesday, December 9, 2015SOU EXTENSION 5 FILED
Wednesday, December 9, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2015SOU EXTENSION 4 GRANTED
Monday, June 1, 2015SOU EXTENSION 4 FILED
Monday, June 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014SOU EXTENSION 3 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 3 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Thursday, July 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 16, 2014SOU EXTENSION 2 GRANTED
Monday, June 23, 2014SOU EXTENSION 2 FILED
Tuesday, July 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Wednesday, December 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2013SOU EXTENSION 1 GRANTED
Monday, December 16, 2013SOU EXTENSION 1 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 7, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2013ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, March 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 4, 2013ASSIGNED TO EXAMINER
Friday, November 16, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 13, 2012NEW APPLICATION ENTERED

Related Keywords

blanent substances pharmaceutical disorders treatment preparations diseases vaccines ophthalmic hepatological sexual